Gts Securities LLC Geron Corp Call Options Transaction History

Gts Securities LLC

  • $54.2 Billion
  • Q1 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.75 - $3.44 $33,075 - $65,016
18,900 Added 32.25%
77,500 $255,000
Q4 2023

Feb 14, 2024
BUY
$1.74 - $2.31 $24,186 - $32,109
13,900 Added 31.1%
58,600 $123,000
Q3 2023

Nov 15, 2023
BUY
$2.11 - $3.28 $94,317 - $146,616
44,700 New
44,700 $94,000

Others Institutions Holding GERN

# of Institutions
250
Shares Held
374M
Call Options Held
1.48M
Put Options Held
1.18M
View Full List

About GERON CORP

GERN Quotes by TradingView
  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.58B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email